February 2025
1. VIJIARATNAM N, Girges C, Auld G, McComish R, et al
   Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial.
   Lancet. 2025 Feb 4:S0140-6736(24)02808-3. doi: 10.1016/S0140-6736(24)02808.
   

   >> Share

   
   August 2024
2. MARRAS C, Ben-Shlomo Y, Darweesh SKL, Llibre-Guerra J, et al
   Validity of the diagnostic criteria for Parkinson's disease - Authors' reply.
   Lancet. 2024;404:652-653.
   

   >> Share

   
   
3. HE Y, Wang JG, Gao CQ
   Validity of the diagnostic criteria for Parkinson's disease.
   Lancet. 2024;404:652.
   

   >> Share

   
   January 2024
4. FOLTYNIE T, Bruno V, Fox S, Kuhn AA, et al
   Medical, surgical, and physical treatments for Parkinson's disease.
   Lancet. 2024;403:305-324.
   

   >> Share

   
   
5. MORRIS HR, Spillantini MG, Sue CM, Williams-Gray CH, et al
   The pathogenesis of Parkinson's disease.
   Lancet. 2024;403:293-304.
   

   >> Share

   
   
6. BEN-SHLOMO Y, Darweesh S, Llibre-Guerra J, Marras C, et al
   The epidemiology of Parkinson's disease.
   Lancet. 2024;403:283-292.
   

   >> Share

   
   
7. THE LANCET
   What next in Parkinson's disease?
   Lancet. 2024;403:219.
   

   >> Share

   
   October 2023
8. VERHOEFF MC, Berendse HW, Lobbezoo F
   The importance of a healthy mouth in Parkinson's disease.
   Lancet. 2023;402:1419-1420.
   

   >> Share

   
   February 2023
9. FERREIRA D, Araujo R
   A professional sportsperson with subtle motor symptoms and signs: early-onset Parkinson's disease.
   Lancet. 2023;401:e18.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share